NATCO records increased revenues,profits!!!
May 28th 2011
The Hyderabad based NATCO Pharma Limited has recorded increased revenues and profits for the financial year ended on 31st March, 2012. The Board met at Hyderabad today and approved the accounts.
The Company has recorded aggregate revenues of Rs. 559 Crores (an increase of 15% over 2011- Rs. 484 Crores) and earned an after tax profit of Rs. 60 Crores (an increase of 12% over 2011 – Rs. 53 Crores).
The growth was driven by a 40% increase in API sales at Rs. 148 Crores from Rs. 106 Crores during 2011, a 22% increase in Formulation sales at Rs. 282 Crores in 2012 from 232 Crores in 2011. The company’s oncology division performed well, recording an increase in sales from Rs. 121 Crores in 2011 to Rs. 148 Crores in 2012. The company’s exports aggregated to Rs. 183 Crores, an increase of 37% over that of 2011 (Rs. 134 Crores).